Table 1.

Data for the 12 affected DBA patients analyzed in this study

DBA patientSexAge, mo*Hb, g/dL*Retic count, ×109/L*Hb, g/dLFerritin level, μg/LMalformationsMutated geneTreatmentChelation
UPN#591 NA NA 6.9 3787 No RPS19 Deferiprone + deferoxamine 
UPN#892 2.5 0.96 8.8 3879 No RPS19 Deferasirox 
UPN#826 0.8 1.9 × 1012/L RBC 0.19 13.1 750 No RPS19 — 
UPN#35 5.6 NA 9.3 1072 Yes, hair anomaly prognathism RPS19 Deferoxamine 
UPN#597 6 anemia reported; 60 (diagnosis confirmed on BM) NA 5% (total EB) NA 14 295 Yes, piebaldism, low hair implantation, short and webbed neck, pterygium colli, “café au lait” spots RPL11 S Metoclopramide good responder stop — 
UPN#1099 7.8 538 No RPL11 Deferasirox 
UPN#905 6.8 85.4 12 70 No RPS26 — 
UPN#590 7 anemia reported; 39 (diagnosis confirmed on BM) NA 1.668 7.6 692 No RPL5 — 
UPN#411 1.71 × 1012/L RBC NA 11 53 Yes, cleft palate RPL5 S Metoclopramide good responder — 
UPN#412 Birth Anemia reported only NA 11.7 275 Yes, supernumerary thumb RPL5 TI — 
UPN#845 NA NA 274 Yes, growth retardation RPL5 — 
UPN#631 NA NA 10.4 89 Yes, short extremities Exome in progress TI — 
DBA patientSexAge, mo*Hb, g/dL*Retic count, ×109/L*Hb, g/dLFerritin level, μg/LMalformationsMutated geneTreatmentChelation
UPN#591 NA NA 6.9 3787 No RPS19 Deferiprone + deferoxamine 
UPN#892 2.5 0.96 8.8 3879 No RPS19 Deferasirox 
UPN#826 0.8 1.9 × 1012/L RBC 0.19 13.1 750 No RPS19 — 
UPN#35 5.6 NA 9.3 1072 Yes, hair anomaly prognathism RPS19 Deferoxamine 
UPN#597 6 anemia reported; 60 (diagnosis confirmed on BM) NA 5% (total EB) NA 14 295 Yes, piebaldism, low hair implantation, short and webbed neck, pterygium colli, “café au lait” spots RPL11 S Metoclopramide good responder stop — 
UPN#1099 7.8 538 No RPL11 Deferasirox 
UPN#905 6.8 85.4 12 70 No RPS26 — 
UPN#590 7 anemia reported; 39 (diagnosis confirmed on BM) NA 1.668 7.6 692 No RPL5 — 
UPN#411 1.71 × 1012/L RBC NA 11 53 Yes, cleft palate RPL5 S Metoclopramide good responder — 
UPN#412 Birth Anemia reported only NA 11.7 275 Yes, supernumerary thumb RPL5 TI — 
UPN#845 NA NA 274 Yes, growth retardation RPL5 — 
UPN#631 NA NA 10.4 89 Yes, short extremities Exome in progress TI — 

—, no chelation; BM, bone marrow; EB, erythroblasts; F, female; Hb, hemoglobin; M, male; NA, not available; RBC, red blood cells; Retic, reticulocyte; S, steroid; T, transfusion dependence; TI, therapeutic independence.

*

At diagnosis.

At the time of the study.

or Create an Account

Close Modal
Close Modal